Sponsored Links
  • VitalGo Systems 1300x380
  • Grifols 1300x380
  • HESC Sponsors Ad 1300x380 Abiomed Biomed Simulation
  • Abbott 1300x380
  • HESC Sponsors Ad 1300x380 CLR Essential Pharma
  • ODI Orthodynamics Company 1300x380
  • Medtronic 1300x380
  • HESC Sponsors Ad 1300x380 Abbot Indiana Donor Network
  • EigenFlow 2 Advanced 1300x380

Premortem Anticoagulation Timing and Dose in Donation After Circulatory Death Multicenter Study of Associations With Graft Function

This multicenter study led by Andreas H. Kramer and his colleagues delves into the critical practice of administering premortem heparin to potential organ donors in controlled donation after circulatory determination of death (DCD). Despite its widespread use, the practice remains controversial due to the potential risk of inducing bleeding and the lack of solid evidence…

Login in to view this article:

You need to be logged in to view the rest of this article. Don't have an account? Register for one below.

Subscribe
Notify of

0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
Sponsored Links
  • Beating Heart Newsletter Ad
  • EigenFlow 2 Advanced 800x800
  • HBP Place Ad Here

Stay Informed! Sign up for our newsletter.

Stay informed with new article notifications and updates. Your email is used for article notification and update purposes only and will never be used for spam.

0
Would love your thoughts, please comment.x
()
x